| Product Information |
|
| Registration Number |
BR-1443
|
| Generic Name |
Factor VIII Inhibitor Bypassing Activity
|
| Brand Name |
Feiba
|
| Dosage Strength |
1000 U/20 mL (50 U/mL)
|
| Dosage Form |
Powder for Solution for
Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Blood Coagulation Factors
|
| Packaging |
500, 1000, and 2500 units (U) per vial supplied with a diluent in a vial containing steril water for injection
|
| Manufacturer |
Baxter AG
|
| Country of Origin |
Austria
|
| Trader |
N/A
|
| Importer |
Takeda Healthcare Philippines Inc.
|
| Distributor |
Takeda Healthcare Philippines Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
19 June 2023
|
| Expiry Date |
19 June 2028
|